Nestlé Health Science, a subsidiary of Switzerland-based chocolate company Nestlé launched at the start of the year, will buy specialty pharmaceutical and diagnostic company Prometheus Laboratories for an undisclosed amount. Luis Cantarell, executive president of Nestlé Health Science, said: "This is a strategic move into gastrointestinal diagnostics. Prometheus’s leading edge diagnostics technology and outstanding sales force…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
